ARS Pharmaceuticals, Inc.SPRYNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P83
Within normal range
vs 2Y Ago
0.4x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 19.21% |
| Q3 2025 | -13.97% |
| Q2 2025 | -32.24% |
| Q1 2025 | -167.97% |
| Q4 2024 | 361.05% |
| Q3 2024 | -52.83% |
| Q2 2024 | -21.61% |
| Q1 2024 | -43.58% |
| Q4 2023 | 51.78% |
| Q3 2023 | 14.42% |
| Q2 2023 | -16.10% |
| Q1 2023 | -3.69% |
| Q4 2022 | -119.19% |
| Q3 2022 | -2.54% |
| Q2 2022 | 11.45% |
| Q1 2022 | -41.05% |
| Q4 2021 | 11.53% |
| Q3 2021 | -25.04% |
| Q2 2021 | 0.00% |
| Q1 2021 | 64.49% |
| Q4 2020 | 0.00% |
| Q2 2020 | -22.50% |
| Q1 2020 | 24.26% |
| Q4 2019 | 0.00% |